PremiumCompany AnnouncementsTotalEnergies Buys Back €47 Million of Its Own Shares in Early April2d agoTTE
PremiumRatingsAstraZeneca: Oncology and CVRM Momentum, Pipeline Progress, and FX Tailwinds Underpin Raised £165 Price Target and Buy Rating3d agoAZN
AstraZeneca: Oncology and CVRM Momentum, Pipeline Progress, and FX Tailwinds Underpin Raised £165 Price Target and Buy Rating
PremiumThe FlyAstraZeneca price target raised to 16,500 GBp from 16,000 GBp at Morgan Stanley3d agoAZN